Interstitial Cystitis: Individualized Support Does Not Mean There Is Nowhere to Start

By Dustin Strong, CHN, ACN

When someone asks me what I would recommend for interstitial cystitis, my most honest answer is:

I would first want to know much more about the person.

Interstitial cystitis, now commonly called interstitial cystitis/bladder pain syndrome or IC/BPS, is not believed to have one universal cause. It may involve some combination of bladder-lining irritation, inflammation, immune activation, pelvic-floor dysfunction, nerve hypersensitivity, hormonal changes and central pain amplification.

That means two people can receive the same diagnosis while having very different variables driving their symptoms.

One person may have a history of recurrent urinary infections. Another may have pelvic-floor tension. Another may have Hunner lesions and localized bladder inflammation. Someone else may have widespread pain, food-triggered flares, allergies, endometriosis or nervous-system sensitization.

This is why I would never want to reduce such a complicated condition to a single supplement or standardized protocol.

But individualized care does not mean we have nowhere to begin.

What I would want to know first

Before making recommendations, I would want to explore questions such as:

• Has infection been properly ruled out with urinalysis and urine culture?

• Is there blood in the urine?

• Does the discomfort increase as the bladder fills and improve after urination?

• Is there a history of recurrent UTIs, kidney stones or pelvic procedures?

• Are Hunner lesions present?

• Has pelvic-floor dysfunction been evaluated?

• Which foods, beverages or activities trigger symptoms?

• Are constipation, endometriosis, vulvodynia or painful intercourse involved?

• Are allergies, histamine symptoms or other inflammatory conditions present?

• Does the person also experience fibromyalgia, migraine, irritable bowel syndrome or widespread pain?

• What medications and supplements are they currently taking?

• What are their kidney function, blood pressure, thyroid status and overall inflammatory picture?

These questions help us determine whether we are primarily looking at a urinary-tract variable, bladder-tissue irritation, immune activity, pelvic-floor dysfunction, nervous-system sensitization or several of these at once.

Where might I begin if I knew nothing else?

If I had to develop an initial starting framework before receiving more information, I might investigate the appropriateness of:

• MediHerb Cranberry Complex

• MediHerb Turmeric Forte

• MediHerb UriCo Phytosynergist

• Standard Process Albaplex

• MediHerb Cat’s Claw Forte

These are not presented as a proven treatment for interstitial cystitis. I would consider them as different tools addressing different parts of the person’s overall equation.

For example, they may lead us to consider urinary-tract and mucosal support, inflammatory balance, immune activity, tissue nutrition and normal elimination pathways. The product choices would then be refined according to the person’s symptoms, history, examination findings, medications and response.

MediHerb describes Cranberry Complex as supporting normal urinary-tract, bladder and urinary mucosal function. However, there is an important caveat: cranberry is not appropriate for everyone with IC/BPS. Cranberry and other acidic substances can provoke a flare in some people with a highly sensitive bladder.

This illustrates why “good for the urinary tract” does not necessarily mean “good for every painful bladder.”

Joseph Antell’s traditional starting framework

Joseph Antell approached these cases through a broader nutritional and tissue-support framework. In his order of importance, he would begin by considering:

1. Dermatrophin PMG

2. Spleen PMG

3. Renatrophin PMG

4. Arginex

He might then consider additional products according to the individual presentation:

• UriCo Phytosynergist

• Min-Chex

• Neuroplex

• Cataplex A-C-P

• Cranberry Complex

• Cataplex B2

• Gotu Kola Complex

• Prolamine Iodine Plus

• Boswellia Complex

• Cramplex

• Chlorophyll Complex

This is not intended to suggest that everyone needs all of these products. Quite the opposite.

The value of such a list is that it reminds us how many systems may need to be considered:

Clinical consideration	Examples from the framework
Bladder and urinary support	Cranberry Complex, UriCo, Albaplex, Arginex
Tissue-focused nutritional support	Dermatrophin PMG, Spleen PMG, Renatrophin PMG
Inflammatory balance	Turmeric Forte, Boswellia Complex
Nervous-system and muscular tension	Min-Chex, Neuroplex, Cramplex
Immune-system considerations	Cat’s Claw Forte, Spleen PMG
Circulation and connective-tissue support	Gotu Kola Complex
Broader nutritional support	Cataplex A-C-P, Cataplex B2, Chlorophyll Complex
Iodine-related considerations	Prolamine Iodine Plus

These are clinical considerations, not established IC/BPS treatment claims. The research supporting many of these products specifically for interstitial cystitis is limited or absent. Their inclusion reflects a traditional functional-nutrition framework that must be applied thoughtfully, not a one-size-fits-all protocol.

Starting somewhere does not mean starting everything

One of the easiest mistakes in functional care is to identify many plausible variables and attempt to address all of them at once.

With a reactive bladder, that can be especially problematic.

If five or ten products are introduced simultaneously and the person improves, we do not know which variable mattered. If symptoms worsen, we do not know what caused the flare.

My preference would usually be to:

1. Establish an appropriate medical evaluation.

2. Identify the most likely dominant variables.

3. Choose the smallest reasonable starting strategy.

4. Introduce products carefully.

5. Track urinary frequency, urgency, pain, food intake and other symptoms.

6. Adjust according to the person’s response.

The response itself becomes useful information.

Safety and interactions still matter

Botanical and nutritional products can interact with medications and may be inappropriate during pregnancy or with certain kidney, liver, gallbladder, blood-pressure, bleeding or thyroid conditions.

For example, formulas containing licorice, uva ursi, turmeric, cat’s claw or iodine each require their own screening considerations. A person experiencing visible blood in the urine, fever, flank pain, difficulty urinating, unexplained weight loss or rapidly worsening symptoms should receive prompt medical evaluation rather than assuming the symptoms are simply another IC flare.

The Strong On Health perspective

My preference will always be to get to know the person and understand as many variables in their equation as possible.

I want to know what happened before the symptoms began, what makes them better, what makes them worse, which systems appear to be involved and what has already been attempted. I also want to know what conventional evaluation has found, because functional and nutritional care should expand the investigation, not replace appropriate medical care.

Interstitial cystitis reminds us why personalization matters. The same diagnosis does not necessarily mean the same cause, and it should not automatically lead to the same protocol.

Still, personalization should never become paralysis.

We may not know the complete equation on the first day, but we can identify a thoughtful place to begin, observe what changes and allow the person’s response to guide what comes next.

That is where individualized care becomes both compassionate and practical.